US4452773A
(en)
|
1982-04-05 |
1984-06-05 |
Canadian Patents And Development Limited |
Magnetic iron-dextran microspheres
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
US4795698A
(en)
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
ES2067018T3
(es)
|
1988-12-28 |
1995-03-16 |
Stefan Miltenyi |
Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos.
|
US5200084A
(en)
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US5925517A
(en)
|
1993-11-12 |
1999-07-20 |
The Public Health Research Institute Of The City Of New York, Inc. |
Detectably labeled dual conformation oligonucleotide probes, assays and kits
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
WO1996013593A2
(en)
|
1994-10-26 |
1996-05-09 |
Procept, Inc. |
Soluble single chain t cell receptors
|
WO1996018105A1
(en)
|
1994-12-06 |
1996-06-13 |
The President And Fellows Of Harvard College |
Single chain t-cell receptor
|
US20020150914A1
(en)
|
1995-06-30 |
2002-10-17 |
Kobenhavns Universitet |
Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
DE19608753C1
(de)
|
1996-03-06 |
1997-06-26 |
Medigene Gmbh |
Transduktionssystem und seine Verwendung
|
US6451995B1
(en)
|
1996-03-20 |
2002-09-17 |
Sloan-Kettering Institute For Cancer Research |
Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
|
AU6467796A
(en)
|
1996-04-24 |
1997-05-15 |
Claude Fell |
Cell separation system for biological fluids like blood
|
SE506700C2
(sv)
|
1996-05-31 |
1998-02-02 |
Mikael Kubista |
Sond och förfaranden för analys av nukleinsyra
|
EP1033411B1
(en)
|
1996-06-04 |
2006-02-22 |
University of Utah Research Foundation |
Fluorescent donor-acceptor pair
|
US6420108B2
(en)
|
1998-02-09 |
2002-07-16 |
Affymetrix, Inc. |
Computer-aided display for comparative gene expression
|
JP2001519143A
(ja)
|
1997-10-02 |
2001-10-23 |
スノル・モレキュラー・コーポレーション |
可溶性の一本鎖t細胞レセプタータンパク質
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
JP2002515243A
(ja)
|
1998-05-19 |
2002-05-28 |
アヴィデックス リミテッド |
多価t細胞受容体複合体
|
GB9812768D0
(en)
|
1998-06-13 |
1998-08-12 |
Zeneca Ltd |
Methods
|
EP1109921A4
(en)
|
1998-09-04 |
2002-08-28 |
Sloan Kettering Inst Cancer |
FOR PROSTATE-SPECIFIC MEMBRANE-ANTI-SPECIFIC FUSION RECEPTORS AND THEIR USE
|
US6410319B1
(en)
|
1998-10-20 |
2002-06-25 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
DE69919029T2
(de)
|
1998-12-24 |
2005-09-08 |
Biosafe S.A. |
Vorrichtung zur bluttrennung, insbesondere zur konzentrierung von hematopoietischen stammzellen
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
CA2410510A1
(en)
|
2000-06-02 |
2001-12-13 |
Memorial Sloan-Kettering Cancer Center |
Artificial antigen presenting cells and methods of use thereof
|
ES2267803T3
(es)
|
2000-08-11 |
2007-03-16 |
University Of Utah Research Foundation |
Sondas de oligonucleotidos marcados individuales.
|
US7446179B2
(en)
|
2000-11-07 |
2008-11-04 |
City Of Hope |
CD19-specific chimeric T cell receptor
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
US20090257994A1
(en)
|
2001-04-30 |
2009-10-15 |
City Of Hope |
Chimeric immunoreceptor useful in treating human cancers
|
JP4317940B2
(ja)
|
2001-08-31 |
2009-08-19 |
イミュノコア・リミテッド |
物質
|
US7939059B2
(en)
|
2001-12-10 |
2011-05-10 |
California Institute Of Technology |
Method for the generation of antigen-specific lymphocytes
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
EP1485075A4
(en)
|
2002-02-20 |
2006-04-26 |
Dyax Corp |
MHC-PEPTIDE COMPLEX BINDING LIGANDS
|
US20030170238A1
(en)
|
2002-03-07 |
2003-09-11 |
Gruenberg Micheal L. |
Re-activated T-cells for adoptive immunotherapy
|
ITCZ20020002A1
(it)
|
2002-04-11 |
2003-10-13 |
Parco Scient E Tecnologico Del |
Dispositivo e metodo per il rilevamento simultaneo di differenti anticorpi e antigeni in campioni clinici, alimentari ed ambientali
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
US20050129671A1
(en)
|
2003-03-11 |
2005-06-16 |
City Of Hope |
Mammalian antigen-presenting T cells and bi-specific T cells
|
CA2567814C
(en)
|
2004-05-27 |
2013-07-23 |
Jon A. Weidanz |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
US20090226474A1
(en)
|
2004-05-27 |
2009-09-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
US20090304679A1
(en)
|
2004-05-27 |
2009-12-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
DK1791865T3
(da)
|
2004-06-29 |
2010-11-01 |
Immunocore Ltd |
Celler der udtrykker en modificeret T-cellerecptor
|
EP1893253B1
(en)
|
2005-03-23 |
2010-05-19 |
Biosafe S.A. |
Integrated system for collecting, processing and transplanting cell subsets, including adult stem cells, for regenerative medicine
|
ES2663323T3
(es)
|
2007-03-30 |
2018-04-12 |
Memorial Sloan-Kettering Cancer Center |
Expresión constitutiva de ligandos coestimuladores en linfocitos T transferidos de manera adoptiva
|
ES2374863T3
(es)
|
2007-12-07 |
2012-02-22 |
Miltenyi Biotec Gmbh |
Centrífuga para separar una muestra en por lo menos dos componentes.
|
US8479118B2
(en)
|
2007-12-10 |
2013-07-02 |
Microsoft Corporation |
Switching search providers within a browser search box
|
RS56844B1
(sr)
|
2007-12-11 |
2018-04-30 |
Univ North Carolina Chapel Hill |
Retrovirusni vektori sa modifikovanim polipurinskim nizom
|
US20120164718A1
(en)
|
2008-05-06 |
2012-06-28 |
Innovative Micro Technology |
Removable/disposable apparatus for MEMS particle sorting device
|
JP5173594B2
(ja)
|
2008-05-27 |
2013-04-03 |
キヤノン株式会社 |
管理装置、画像形成装置及びそれらの処理方法
|
CA2735456C
(en)
|
2008-08-26 |
2021-11-16 |
City Of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
CA2777053A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
EP4049674A1
(en)
|
2009-11-03 |
2022-08-31 |
City of Hope |
Truncated epidermal growth factor receptor (egfrt) for transduced t cell selection
|
WO2011140324A1
(en)
|
2010-05-07 |
2011-11-10 |
Glaxosmithkline Llc |
Indoles
|
WO2012005805A1
(en)
|
2010-05-07 |
2012-01-12 |
Glaxosmithkline Llc |
Azaindazoles
|
WO2011140325A1
(en)
|
2010-05-07 |
2011-11-10 |
Glaxosmithkline Llc |
Indazoles
|
US9175331B2
(en)
|
2010-09-10 |
2015-11-03 |
Epizyme, Inc. |
Inhibitors of human EZH2, and methods of use thereof
|
US8895245B2
(en)
|
2010-09-10 |
2014-11-25 |
Epizyme, Inc. |
Inhibitors of human EZH2 and methods of use thereof
|
WO2012068589A2
(en)
|
2010-11-19 |
2012-05-24 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
MX347078B
(es)
|
2010-12-09 |
2017-04-10 |
Univ Pennsylvania |
Uso de celulas t modificadas por receptor de antigeno quimerico para tratar cancer.
|
JP2014511389A
(ja)
|
2011-02-28 |
2014-05-15 |
エピザイム インコーポレイテッド |
置換6,5−縮合二環式ヘテロアリール化合物
|
WO2012129514A1
(en)
|
2011-03-23 |
2012-09-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
SG193956A1
(en)
|
2011-04-01 |
2013-11-29 |
Sloan Kettering Inst Cancer |
T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
|
JO3438B1
(ar)
|
2011-04-13 |
2019-10-20 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
TWI598336B
(zh)
|
2011-04-13 |
2017-09-11 |
雅酶股份有限公司 |
經取代之苯化合物
|
US8398282B2
(en)
|
2011-05-12 |
2013-03-19 |
Delphi Technologies, Inc. |
Vehicle front lighting assembly and systems having a variable tint electrowetting element
|
US20130078250A1
(en)
|
2011-08-23 |
2013-03-28 |
Oliver Ast |
Bispecific t cell activating antigen binding molecules
|
AU2012315566A1
(en)
|
2011-09-30 |
2014-04-17 |
Glaxosmithkline Llc |
Methods of treating cancer
|
CA2854447A1
(en)
|
2011-11-04 |
2013-05-10 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Method of treatment
|
MX359234B
(es)
|
2011-11-11 |
2018-09-20 |
Hutchinson Fred Cancer Res |
Inmunoterapia de celulas t objetivadas en ciclina a1 para cancer.
|
EP2780014A4
(en)
|
2011-11-18 |
2015-07-01 |
Constellation Pharmaceuticals Inc |
METHYLATION MODIFICATION ENZYME MODULATORS, COMPOSITIONS AND USES THEREOF
|
WO2013075084A1
(en)
|
2011-11-18 |
2013-05-23 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
WO2013078320A1
(en)
|
2011-11-21 |
2013-05-30 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
CA2862289C
(en)
|
2012-02-10 |
2019-11-26 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
EP2814846B1
(en)
|
2012-02-13 |
2020-01-08 |
Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
WO2013126726A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Double transgenic t cells comprising a car and a tcr and their methods of use
|
EP4190777A1
(en)
|
2012-04-13 |
2023-06-07 |
Epizyme, Inc. |
Hbr salt form for ezh2 inhibition
|
AU2013256159B2
(en)
|
2012-05-03 |
2018-08-09 |
Fred Hutchinson Cancer Center |
Enhanced affinity T cell receptors and methods for making the same
|
SG10201701339RA
(en)
|
2012-08-20 |
2017-03-30 |
Seattle Children S Hospital Dba Seattle Children S Res Inst |
Method and compositions for cellular immunotherapy
|
WO2014055668A1
(en)
|
2012-10-02 |
2014-04-10 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for immunotherapy
|
CA2888021A1
(en)
|
2012-10-15 |
2014-04-24 |
Epizyme, Inc. |
Substituted n-((2-oxo-1,2-dihydropyridin-3-yl)-methyl)-benzamide compounds and their use in the treatment of ezh2-mediated disorders
|
EP2908843B1
(en)
|
2012-11-19 |
2019-09-04 |
Agency For Science, Technology And Research |
Treating cancer
|
US9895390B2
(en)
|
2012-12-10 |
2018-02-20 |
Children's Medical Center Corporation |
Methods and assays for combination treatment of cancer
|
JP5372297B1
(ja)
|
2012-12-20 |
2013-12-18 |
三菱電機株式会社 |
車載装置及びプログラム
|
WO2014100665A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
1,4-pyridone bicyclic heteroaryl compounds
|
EP2970305B1
(en)
|
2013-03-15 |
2017-02-22 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
US9243001B2
(en)
|
2013-03-15 |
2016-01-26 |
Epizyme, Inc. |
Substituted benzene compounds
|
EP2970306A4
(en)
|
2013-03-15 |
2016-08-03 |
Epizyme Inc |
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS CONDENSED IN 6.5
|
UY35468A
(es)
|
2013-03-16 |
2014-10-31 |
Novartis Ag |
Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
|
JP6373973B2
(ja)
|
2013-04-30 |
2018-08-15 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
Zesteホモログ2エンハンサー阻害剤
|
EP3022184B1
(en)
|
2013-07-19 |
2017-09-27 |
Epizyme, Inc. |
Substituted benzene compounds
|
US9624205B2
(en)
|
2013-07-19 |
2017-04-18 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
US9969716B2
(en)
|
2013-08-15 |
2018-05-15 |
Constellation Pharmaceuticals, Inc. |
Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
|
US9108442B2
(en)
|
2013-08-20 |
2015-08-18 |
Ricoh Company, Ltd. |
Image forming apparatus
|
MX2021012208A
(es)
|
2013-10-04 |
2023-01-19 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos.
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MY179802A
(en)
|
2013-10-16 |
2020-11-16 |
Eisai R&D Man Co Ltd |
Hydrochloride salt form for ezh2 inhibition
|
SG11201607006TA
(en)
|
2014-03-17 |
2016-10-28 |
Daiichi Sankyo Co Ltd |
1,3-benzodioxole derivative
|
MX2016012021A
(es)
|
2014-03-19 |
2017-04-13 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
|
IL292038A
(en)
|
2014-04-23 |
2022-06-01 |
Juno Therapeutics Inc |
Methods for enriching and producing immune cell populations for stress treatment
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA2965729A1
(en)
|
2014-10-28 |
2016-05-06 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Enhancer of zeste homolog 2 inhibitors
|
CA2966538A1
(en)
|
2014-11-05 |
2016-05-12 |
Juno Therapeutics, Inc. |
Methods for transduction and cell processing
|
CN113388036A
(zh)
|
2014-12-05 |
2021-09-14 |
纪念斯隆-凯特琳癌症中心 |
靶向b-细胞成熟抗原的抗体及其用途
|
EP3227432B1
(en)
|
2014-12-05 |
2023-10-11 |
Memorial Sloan Kettering Cancer Center |
Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof
|
IL252621B1
(en)
|
2014-12-05 |
2024-02-01 |
Memorial Sloan Kettering Cancer Center |
G-protein receptor-directed chimeric antigen receptors and their use
|
IL285101B2
(en)
|
2014-12-05 |
2024-03-01 |
Memorial Sloan Kettering Cancer Center |
G protein-coupled receptor-directed antibodies and methods of use
|
WO2016130396A1
(en)
|
2015-02-13 |
2016-08-18 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
WO2016201328A1
(en)
|
2015-06-10 |
2016-12-15 |
Epizyme, Inc. |
Ezh2 inhibitors for treating lymphoma
|
CN107847497B
(zh)
|
2015-07-30 |
2021-03-30 |
第一三共株式会社 |
用于成人t细胞白血病/淋巴瘤的治疗和/或预防剂
|
US20180221362A1
(en)
|
2015-08-03 |
2018-08-09 |
Constellation Pharmaceuticals, Inc. |
Ezh2 inhibitors and modulation of regulatory t-cell function
|
US10577350B2
(en)
|
2015-08-28 |
2020-03-03 |
Constellation Pharmaceuticals, Inc. |
Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide
|
MA45406A
(fr)
|
2016-06-17 |
2019-04-24 |
Epizyme Inc |
Inhibiteurs d'ezh2 pour traiter le cancer
|
US11624068B2
(en)
*
|
2016-07-15 |
2023-04-11 |
Tufts Medical Center, Inc. |
Compositions and methods for improving immune system function
|
EP3529242A1
(en)
|
2016-10-19 |
2019-08-28 |
Constellation Pharmaceuticals, Inc. |
Synthesis of inhibitors of ezh2
|
TW201831181A
(zh)
|
2017-01-19 |
2018-09-01 |
日商第一三共股份有限公司 |
用以用於治療htlv-1相關脊髓病之醫藥組成物
|
US20230201212A1
(en)
|
2017-06-13 |
2023-06-29 |
Epizyme, Inc. |
Inhibitors of ezh2 and methods of use thereof
|
US11459315B2
(en)
|
2017-11-09 |
2022-10-04 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|